Regulatory T cells for immunotherapy of autoimmune diseases: from the bench to the bedside

Author： Rutella Sergio   Danese Silvio   Leone Giuseppe  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.15, Iss.11, 2005-11, pp. : 1595-1616

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natural and Induced Regulatory T Cells: Targets for Immunotherapy of Autoimmune Disease and Allergy

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 3, 2006-09 ,pp. : 141-148

Bentham Science Publishers

Access to resources Recommend Favorite

Translating Induced Pluripotent Stem Cells from Bench to Bedside: Application to Retinal Diseases

By  

Current Gene Therapy, Vol. 13, Iss. 2, 2013-04 ,pp. : 139-151

Bentham Science Publishers

Access to resources Recommend Favorite

Reserve Mechanisms in Neurodegenerative Diseases: From Bench to Bedside and Back Again

By  

Current Medicinal Chemistry, Vol. 19, Iss. 36, 2012-12 ,pp. : 6112-6118

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular NO: from bench to bedside

By Tsikas Dimitrios  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. : 3-3

Springer Publishing Company

Access to resources Recommend Favorite

CETUXIMAB: From Bench to Bedside

By  

Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-01 ,pp. : 80-95

Bentham Science Publishers

Access to resources Recommend Favorite